Effect of gomutra plus capsule on primary obesity double blind placebo control trial- POST MARKETTING SURVILLENCE

A Randomised Double Blind Placibo Controlled Clinical Trial To Evaluate Efficacy Of Gomutra Plus Capsule On Obesity

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051595

Enrollment

Registered

2023-04-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K928- Other specified diseases of the digestive system

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: all patients within criteria detected obesity with reference of BMI and BMR

Exclusion criteria

Exclusion criteria: 1. pregant woman 2.giving breast feeding 3. participants in another trial 4. known case of any cardiac disease including congestive heart failure, cardiac arrythmias, unstable angina 5. myocardial infraction within the last 6 months or uncontrolled malignant hypertension 6. high risk of developing coronary artery diseases 7.any kind of malignancy 8.uncontrolled DM 9.Acute Renal faliure 10. Chronic renal faliure 11. Known HIV positive 12. patient on Concurrent use of corticosteroids,

Design outcomes

Primary

Measure	Time frame
reduction in BMI, reduction in weightTimepoint: 15days	—

Secondary

Measure	Time frame
inches loss in circumference of chest waist and abdomenTimepoint: 15days	—

Countries

India

Contacts

Public ContactDr Jai Kiran Kini

Dr G D Pol Foundation ymt Ayurvedic Medical College Kharghar navi mumbai

vd.jaikini@gmail.com9869046901

Outcome results